Culbertson v. Commissioner of Social Security

CourtDistrict Court, N.D. Ohio
DecidedApril 22, 2025
Docket1:24-cv-01847
StatusUnknown

This text of Culbertson v. Commissioner of Social Security (Culbertson v. Commissioner of Social Security) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Culbertson v. Commissioner of Social Security, (N.D. Ohio 2025).

Opinion

IN THE UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

JOCYELYNN S. CULBERTSON, ) Case No. 1:24-cv-01847 ) Plaintiff, ) JUDGE DAVID A. RUIZ ) v. ) MAGISTRATE JUDGE ) REUBEN J. SHEPERD COMMISSIONER OF ) SOCIAL SECURITY, ) ) REPORT AND RECOMMENDATION Defendant. )

I. Introduction Plaintiff Jocyelynn Culbertson seeks judicial review of the final decision of the Commissioner of Social Security, denying her application for disability insurance benefits (“DIB”) under Title II of the Social Security Act. This matter is before me pursuant to 42 U.S.C. §§ 405(g), 1383(c)(3), and Local Rule 72.2(b). Because the Administrative Law Judge (“ALJ”) applied proper legal standards and reached a decision supported by substantial evidence, I recommend that the Commissioner’s final decision denying Culbertson’s application for DIB be affirmed. II. Procedural History Culbertson filed for DIB on December 20, 2021, alleging a disability onset date of March 26, 2021. (Tr. 196). The claims were denied initially and on reconsideration. (Tr. 75-84, 86-96). She then requested a hearing before an ALJ. (Tr. 113). Culbertson (represented by counsel) and a vocational expert (“VE”) testified before the ALJ on July 31, 2023. (Tr. 38-62). On September 13, 2023, the ALJ issued a written decision finding Culbertson not disabled. (Tr. 15-37). The Appeals Council denied her request for review on September 11, 2024, making the hearing decision the final decision of the Commissioner. (Tr. 1-3; see 20 C.F.R. §§ 404.955, 404.981). Culbertson timely filed this action on October 23, 2024. (ECF Doc. 1).

III. Evidence A. Personal, Educational, and Vocational Evidence Culbertson was 29 years old on the alleged onset date, making her a younger individual according to Agency regulations. (See Tr. 31). She graduated from high school. (See id.). In the past, she worked as a medical assistant and as a cashier. (Id.). B. Relevant Medical Evidence1 Culbertson received mental health treatment from Chandravadan P. Patel, M.D., on March 29, 2021. (Tr. 540). She stated she had not been functioning well for the past two months. (Id.). She reported increased mental and physical health symptoms, including increased anxiety, IBS, headaches, kidney disease, and UTIs. (Id.). Culbertson stated she tried to use FMLA time to

go from full-time work to part-time, but her paperwork was not processed properly. (Id.). She had resigned from her job because she felt unable to work full-time. (Id.). On examination, Culbertson was oriented, had a depressed mood and affect, but had normal thought process with no attention deficit, no impairment in abstract reasoning or concentration, no impairment in long term or short-term memory, and she had appropriate judgment in everyday situations and in social situations. (Tr. 541). Dr. Patel noted Culbertson had failed trials of Zoloft, Lexapro, and Luvox. (Tr. 542). He started her on Amitriptyline 100 mg and Trintellix 10 mg. (Id.).

1 Culbertson raises error only with the mental health limitations included in her RFC. (ECF Doc. 6, pp. 6- 11). I therefore limit my review of the medical evidence only to these issues and treat any as argument as to her other impairments waived. See McPherson v. Kelsey, 125 F.3d 989 (6th Cir. 1997). On May 24, 2021, Culbertson attended a telehealth visit with David Lamport, PA, for medication review and refill. (Tr. 450-52). She reported chronic abdominal pain and requested a refill of Tramadol. (Tr. 450). Culbertson also reported doing much better on the amitriptyline 75 mg but requested a lower dose because it seemed to cause her problems with increased appetite.

(Id.). PA Lamport refilled the Tramadol and recommended Culbertson slowly decrease her dose of amitriptyline to 25 mg daily. (Tr. 452). Culbertson followed up with Dr. Patel on July 21, 2021. (Tr. 536). She reported that she had considerably improved since the last visit. (Id.). She had found a part-time job working 16 to 24 hours per week, which helped her take care of her multiple medical issues and to spend more time with her mother. (Id.). The reduced amitriptyline dose had caused a recurrence of her migraines and IBS; Dr. Patel agreed that an increase to 50 mg amitriptyline was appropriate. (Id.). On examination, Culbertson was oriented, had euthymic mood and affect, and all areas were noted as normal and appropriate. (Tr. 537). Dr. Patel continued Xanax, Ambien, and Trintellix, and increased amitriptyline. (Tr. 538).

On October 13, 2021, Culbertson had a telehealth visit with Dr. Patel. (Tr. 533). She reported that the new job was causing an increase in her anxiety, obsessive thinking, and depression, as well as difficulty paying attention and staying focused. (Id.). The increase in anxiety had also exacerbated her IBS symptoms. (Id.). Dr. Patel continued Culbertson’s medications and recommended follow up in four weeks. (Tr. 535). On January 5, 2022, Culbertson followed up with Dr. Patel. (Tr. 578). She reported that she continued to struggle with chronic multiple psychosocial stressors from her chronic illnesses. (Id.). She reported struggling with ADHD since she was in elementary school, but past treatment had focused on her physical health symptoms. (Id.). However, she reported significant functional improvement and reduced obsessive thinking and ritualistic behavior since adding Adderall. (Id.). On examination, Culbertson had an anxious mood and affect and pressured speech, but all other areas were described as appropriate and normal. (Tr. 580). Dr. Patel continued Adderall, Xanax, Lexapro, Ambien, and Amitriptyline, and recommended follow up in 12 weeks. (Id.).

On February 7, 2022, Culbertson had an emergency telehealth visit with Dr. Patel, describing increasing flashbacks surrounding her father’s death and mother’s illness. (Tr. 575, 1049). She did not feel like she could continue working even part-time with the recurring flashbacks. (Id.). Dr. Patel continued all medications. (Tr. 576-77, 1050-51). Culbertson met with Dr. Patel on February 23, 2022, as an emergency appointment. (Tr. 572). She reported that she was still having increased flashbacks and nightmares, insomnia, and increased migraines. (Id.). She had been missing work at her part-time job, and she gave her two weeks’ notice to avoid being fired. (Id.). On examination, she was oriented x3, had an anxious and depressed mood and affect, with pressured speech and thought processes, she had impaired concentration and attention deficit, with a lack of energy. (Tr. 574). Dr. Patel continued

Culbertson on all medications and recommended follow up in 12 weeks. (Id.). That same day, Culbertson met with Ashlee Armstrong, N.P. to discuss disability. (Tr. 587). Culbertson reported she had stopped working that month because of the amount of stress she was feeling, including PTSD, worsening anxiety and depression, migraines with aura, frequent UTI, kidney stones, and IBS. (Id.). She described having panic attacks when she has to work, with diarrhea and vomiting the night before and on the drive to work, as well as hives. (Id.). She felt she could not transition to a different job because of needing frequent bathroom breaks. (Id.). N.P. Armstrong recommended Culbertson continue to follow with specialists and suggested that the hives could be stress induced, but she had not seen Culbertson in person for treatment of this condition. (Tr. 590). Culbertson followed up with Dr. Patel on May 25, 2022, and reported that she continued to struggle with chronic anxiety, obsessive thinking, PTSD, migraine headaches, and IBS,

despite taking all medications as prescribed. (Tr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Angela M. Jones v. Commissioner of Social Security
336 F.3d 469 (Sixth Circuit, 2003)
Barbara Combs v. Commissioner of Social Security
459 F.3d 640 (Sixth Circuit, 2006)
David Bowen v. Commissioner of Social Security
478 F.3d 742 (Sixth Circuit, 2007)
Debra Rogers v. Commissioner of Social Security
486 F.3d 234 (Sixth Circuit, 2007)
Fleischer v. Astrue
774 F. Supp. 2d 875 (N.D. Ohio, 2011)
Walton v. Astrue
773 F. Supp. 2d 742 (N.D. Ohio, 2011)
Phillip Stacey v. Commissioner of Social Security
451 F. App'x 517 (Sixth Circuit, 2011)
Jerry Rudd v. Commissioner of Social Security
531 F. App'x 719 (Sixth Circuit, 2013)
Shepard v. Commissioner of Social Security
705 F. App'x 435 (Sixth Circuit, 2017)
United States v. Patrick Wandahsega
924 F.3d 868 (Sixth Circuit, 2019)
Randy Berkshire v. Debra Dahl
928 F.3d 520 (Sixth Circuit, 2019)
McPherson v. Kelsey
125 F.3d 989 (Sixth Circuit, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
Culbertson v. Commissioner of Social Security, Counsel Stack Legal Research, https://law.counselstack.com/opinion/culbertson-v-commissioner-of-social-security-ohnd-2025.